Year: 2026
Type: preprint
Abstract: Selenium is an essential micronutrient widely found in dietary supplements and fortified foods and is required for selenoprotein synthesis and function. Although the molecular mechanisms of selenium-dependent selenoprotein translation are well understood, its uptake mechanisms remain only partially characterized. Using a CRISPR-based loss-of-function screen, we identify the solute carrier SLC26A6 as a direct selenite transporter. Using biochemical, cellular, and in vivo studies, we show that SLC26A6 directly transports selenite and promotes selenoprotein translation, redox homeostasis, and ferroptosis resistance. Additionally, we report the first human-specific SLC26A6 inhibitor and determine the structure of the SLC26A6-inhibitor complex by cryo-electron microscopy. These findings identify a previously uncharacterized route of inorganic selenium uptake and establish SLC26A6 as a pharmacologically tractable determinant of selenoprotein synthesis, redox homeostasis, and ferroptosis resistance.
Authors: Sena Atici, Panagiotis Kreouzis, Gholamreza Fazeli, Maria Schwarz, Zhiyi Chen, David Tippett, Ancely Ferreira dos Santos, Ana Clara Najenson, Mami Sato, Shibo Sun, Florencio Porto Freitas, Jonas Groeninger, Kamini Kaushal, Mostafa Ejtehadifar, Hana Nuskova, Nikolas Gunkel, Felix Knauf, Namgyu Lee, Enrico Girardi, Giulio Superti-Furga, Martin Fassnacht, Chen Deng, Eikan Mishima, Bettina Proneth, Marcus Conrad, Hamed Alborzinia, Anna Patricia Kipp, Raimund Dutzler, Jose Pedro Friedmann Angeli
Institutions: University of Würzburg, University of Zurich, Friedrich Schiller University Jena, Charité – Universitätsmedizin Berlin, German Cancer Research Center, DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Dankook University, Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine, Medical University of Vienna, Universitätsklinikum Würzburg, Helmholtz Munich
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: green
Funders: European Commission, Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, National Research Foundation of Korea, José Carreras Leukämie-Stiftung, Julius-Maximilians-Universität Würzburg, Ministry of Science and ICT, South Korea, Horizon 2020 Framework Programme
Awards: G1740861664, G1784432850, G239731032, G2424529998, G2810377833, G3235113436, G3246393429, G3809606880, G4135729386, G4692099656, G7063645292, G7097013464, G7647055356, G7901191459, Koordinationsfonds, G825409221, Entwicklung eines Lipidbasierten FerroptoseBiomarkers für die Analyse neurodegenerativer Erkrankungen
OpenAlex ID: W7235723754
